RHOC and neoplasm: S1PR2 is also involved in negative regulation of tumor angiogenesis and tumor growth in vivo via RhoC activation [167], although one study has shown that the growth of SKOV3 cells could be decreased by S1PR2 inhibition in vitro and in vivo [168].